Rocket Pharmaceuticals (RCKT) Selling, General & Administrative (2014 - 2026)
Rocket Pharmaceuticals (RCKT) recorded Selling, General & Administrative of $17.43 million in Q2 2026, down 30.4% from $25.02 million a year earlier but up 2.2% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Selling, General & Administrative (2014 - 2026) Analysis & Trends
On a TTM basis, Rocket Pharmaceuticals' Selling, General & Administrative came in at $67.52 million as of Jun 30, 2026, down 36.3% year-over-year; for FY2025, it was $86.5 million, down 15.2% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $101.96 million in FY2024 (+39.1%), $73.32 million in FY2023 (+24.7%), $58.77 million in FY2022 (+40.7%) and $41.77 million in FY2021 (+44.7%).
- Quarterly Selling, General & Administrative has ranged from $10.03 million in Q3 2021 to $28.45 million in Q1 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for five consecutive quarters, with an average decline of 7.7% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 75.0% in Q3 2021, against a decline of 42.0% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $17.06 million (Q1 2026), $14.68 million (Q4 2025) and $18.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Rocket Pharmaceuticals | 280.42 Mn | 280.42 Mn | - | 17.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.43 Mn |
| Mar 31, 2026 | 17.06 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 18.35 Mn |
| Jun 30, 2025 | 25.02 Mn |
| Mar 31, 2025 | 28.45 Mn |
| Dec 31, 2024 | 25.34 Mn |
| Sep 30, 2024 | 27.11 Mn |
| Jun 30, 2024 | 27.37 Mn |
| Mar 31, 2024 | 22.15 Mn |
| Dec 31, 2023 | 21.54 Mn |
| Sep 30, 2023 | 18.59 Mn |
| Jun 30, 2023 | 17.37 Mn |
| Mar 31, 2023 | 15.82 Mn |
| Dec 31, 2022 | 19.05 Mn |
| Sep 30, 2022 | 15.11 Mn |
| Jun 30, 2022 | 12.85 Mn |
| Mar 31, 2022 | 11.77 Mn |
| Dec 31, 2021 | 11.32 Mn |
| Sep 30, 2021 | 10.03 Mn |
API Access
Rocket Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();